Jinhai Medical Technology Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-106.00
-18.00
4.00
0.00
8.00
0.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-12.00
-20.00
-2.00
-6.00
25.00
13.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-21.00
-10.00
26.00
19.00
39.00
46.00
Cash Flow from Investing Activities
-53.00
-39.00
-7.00
-16.00
-34.00
13.00
Cash Flow from Financing Activities
19.00
80.00
-21.00
-27.00
-21.00
-27.00
Net Cash Inflow / Outflow
-56.00
28.00
-4.00
-23.00
-17.00
32.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
-2.00
-1.00
0.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jinhai Medical Technology Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-106.422856479007
205.037570856005
-311.00
-151.90%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-12.2321766787469
-188.30257584695
176.00
93.50%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-21.8369168393859
158.296681005641
-179.00
-113.79%
Cash Flow from Investing Activities
-53.056701422326
134.290880908751
-187.00
-139.51%
Cash Flow from Financing Activities
19.1919640778239
-138.068316776037
157.00
113.90%
Net Cash Inflow / Outflow
-56.9277912256717
155.587205623223
-211.00
-136.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.2261370417837
1.06796048486682
-2.00
-214.81%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -111.42% vs -139.52% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-21.84
-10.33
-111.42%






